Avapritinib in Göttingen geöffnet.
A Phase 1/2, Multicenter, Open-label, Single-arm Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of Avapritinib in Pediatric Patients with Relapsed / Refractory Solid Tumors Harboring a Mutation in KIT or PDGFRA
Weitere Informationen finden Sie auf 2020-005234-15 .
Titel der Studie:
A Phase 1/2, Multicenter, Open-label, Single-arm Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of Avapritinib in Pediatric Patients with Relapsed / Refractory Solid Tumors Harboring a Mutation in KIT or PDGFRA